Quantcast

Latest Prostate cancer Stories

2014-06-27 12:26:51

OWINGS MILLS, Md., June 27, 2014 /PRNewswire-USNewswire/ -- In ongoing support of prostate cancer research, Sanford Siegel, M.D., President and CEO of Chesapeake Urology Associates, presented the Urology Care Foundation with a check for $114,248 in support of its prostate cancer research efforts. The funds, which were raised through the Zero Prostate Cancer Challenge (ZPCC) 10K/5K run in September 2013, were presented at the AUA Annual Meeting in Orlando, Florida on May 16, 2014. The...

2014-06-26 08:26:57

LONDON, June 26, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: KOL Insight: Prostate Cancer: Competition intensifies in race to the tophttp://www.reportbuyer.com/pharma_healthcare/diseases/kol_insight_prostate_cancer_competition_intensifies_race_top.html IntroductionThe Prostate Cancer market has seen a number of progressive changes in recent years. The launches of Johnson & Johnson's Zytiga (abiraterone acetate) and Medivation/Astellas's Xtandi...

2014-06-25 23:12:14

To mark National Men’s Health Awareness Month, the Editorial Board of Living with a Disability magazine has published an important new article on how prostate cancer can become a disabling condition. San Antonio. TX (PRWEB) June 25, 2014 To mark National Men’s Health Awareness Month, which occurs every June, the Editorial Board of Living with a Disability magazine has published an important new article on how prostate cancer can become a disabling condition. As the article...

2014-06-24 23:13:50

On June 20, the FDA issued a warning that Docetaxel may cause intoxication. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) June 24, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on Docetaxel. The FDA issued a safety communication on June 20, warning that Docetaxel may cause patients to experience...

2014-06-24 14:03:33

Mayo Clinic A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting. Their study, published in Cancer Research, reveals that the gene NPTX2, plays an essential role in this cancer type, which is resistant to common chemotherapy and has a five-year overall survival rate of less than 10 percent in patients with metastatic disease....

2014-06-24 08:29:35

Yet Canadians in the dark about cancer survival rates OTTAWA, June 24, 2014 /CNW/ - Cancer isn't always a matter of life and death anymore - today, an increasing number of Canadians are living with cancer as a chronic condition. However, the majority of Canadians and the healthcare system have not necessarily responded to this shift. "The fact is, 63 per cent of Canadian cancer patients live longer than five years after diagnosis(i), and if a cancer patient survives past one year,...

2014-06-23 12:29:48

PARIS, June 23, 2014 /PRNewswire/ -- OSE Pharma SA receives a positive agreement to initiate a Phase 3 clinical trial with OSE-2101, a therapeutic cancer vaccine for non-small cell lung cancer (NSCLC) OSE Pharma SA, a European cancer immunotherapy company with a specific T cytotoxic technology, today announced that it has received positive feedback from an end of Phase 2 / Pre-Phase 3 meeting with the U.S. Food and Drug Administration (FDA) and Scientific Advice from...

2014-06-23 12:28:59

WESTERVILLE, Ohio, June 23, 2014 /PRNewswire/ -- Columbus CyberKnife, a service of Mount Carmel St. Ann's Hospital, has reached an important milestone with the treatment of its 1,000(th) patient. This month marks four years of operation for Columbus CyberKnife, the area's only CyberKnife(®) treatment provider and one of only four in Ohio. http://photos.prnewswire.com/prnvar/20140407/DA98217 "This is a testament to our team's specialized expertise in stereotactic radiosurgery and...

2014-06-20 08:23:49

Company Refutes Latest Feuerstein False Headline and Attacks BETHESDA, Md., June 20, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today refuted Adam Feuerstein's latest false headline and attack on the Company, and reaffirmed the Company's recent interim data announcements from its Phase I/II clinical trial of DCVax-Direct for all inoperable solid tumors....

2014-06-18 04:21:16

Unique Immuno-Oncolytic Therapy Gets Closer to a More Effective, Safer Cancer Treatment and Potential Cure CLEVELAND, June 18, 2014 /PRNewswire-USNewswire/ --­­ Western Oncolytics Ltd., a biotech company specializing in immuno-oncolytic cancer therapies, has closed $275,000 in seed funding. The proceeds are planned to set a path toward clinical trials and execute initial manufacturing for its novel virus-based cancer therapy, which delivers genes to guide the immune system to kill...


Word of the Day
bodacious
  • Remarkable; prodigious.
  • Audacious; gutsy.
  • Completely; extremely.
  • Audaciously; boldly.
  • Impressively great in size; enormous; extraordinary.
This word is probably from the dialectal 'boldacious,' a blend of 'bold' and 'audacious.'
Related